Overall rank by patents
#29,727
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 18 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F01D (NON-POSITIVE DISPLACEMENT MACHINES OR ENGINES, e.g. STEAM TURBINES).
The verdict
PIPL holds 9 US patents across 18 technology areas, rank #29,727 of 50,000 tracked assignees.
PIPL Limited has been granted 9 US utility patents between 2021 and 2024, placing PIPL Limited at rank #29,727 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in F01D (NON-POSITIVE DISPLACEMENT MACHINES OR ENGINES, e.g. STEAM TURBINES). As a Foreign Corporation, PIPL Limited is one of the more focused assignees in the PatentsView dataset. By volume, PIPL sits between Pharma Foods International Co., Ltd. (9 patents, rank #29,723) and Plantarc BIO Ltd. (9 patents, rank #29,731) - the closest US assignees by grant volume. The composite Innovation Score of 53.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. PIPL Limited's 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark PIPL Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PHARMA FOODS INTERNATIONAL CO., LTD.
9 patents
PHARMAIN CORPORATION
9 patents
PI INDUSTRIES LTD.
9 patents
PINNACLE SEED, INC.
9 patents
PIRAMAL PHARMA LIMITED
9 patents
PITT-OHIO Express, LLC
9 patents
PLANET LABS PBC
9 patents
PLANTARC BIO LTD.
9 patents
PIPL LIMITED
9 patents
What this shows PIPL holds 9 patents at rank #29,727, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,727 in granted patent volume.
Other assignees with the most granted patents in PIPL's primary technology class.
PIPL's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 9% higher than 91% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 11.1% |
| 2022 | 5 | 55.6% |
| 2023 | 2 | 22.2% |
| 2024 | 1 | 11.1% |
Top 15 of 18 technology areas
Overall rank by patents
#29,727
Across all tracked assignees
53.7 out of 100
How to use this portfolio
PIPL's 9 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.